nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—SIGMAR1—Raloxifene—osteoporosis	0.185	0.288	CbGbCtD
Iloperidone—HTR6—Raloxifene—osteoporosis	0.139	0.216	CbGbCtD
Iloperidone—CYP1A2—Estropipate—osteoporosis	0.044	0.0684	CbGbCtD
Iloperidone—CYP3A7—Estradiol—osteoporosis	0.0327	0.0509	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0327	0.0509	CbGbCtD
Iloperidone—CYP3A5—Estradiol—osteoporosis	0.0246	0.0382	CbGbCtD
Iloperidone—CYP3A4—Estropipate—osteoporosis	0.0231	0.0359	CbGbCtD
Iloperidone—CYP3A4—Calcitriol—osteoporosis	0.0231	0.0359	CbGbCtD
Iloperidone—CYP1A2—Conjugated Estrogens—osteoporosis	0.0208	0.0324	CbGbCtD
Iloperidone—CYP2D6—Cholecalciferol—osteoporosis	0.0187	0.029	CbGbCtD
Iloperidone—CYP3A4—Ergocalciferol—osteoporosis	0.0184	0.0287	CbGbCtD
Iloperidone—CYP1A2—Estradiol—osteoporosis	0.0183	0.0284	CbGbCtD
Iloperidone—CYP3A4—Raloxifene—osteoporosis	0.0154	0.0239	CbGbCtD
Iloperidone—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0149	0.0231	CbGbCtD
Iloperidone—CYP3A4—Cholecalciferol—osteoporosis	0.0119	0.0185	CbGbCtD
Iloperidone—CYP3A4—Conjugated Estrogens—osteoporosis	0.0109	0.017	CbGbCtD
Iloperidone—CYP3A4—Estradiol—osteoporosis	0.00957	0.0149	CbGbCtD
Iloperidone—SIGMAR1—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.00214	1	CbGdCrCtD
Iloperidone—Hepatobiliary disease—Conjugated Estrogens—osteoporosis	0.000408	0.00152	CcSEcCtD
Iloperidone—Myalgia—Calcitriol—osteoporosis	0.000408	0.00152	CcSEcCtD
Iloperidone—Infection—Alendronate—osteoporosis	0.000408	0.00152	CcSEcCtD
Iloperidone—Dry mouth—Ibandronate—osteoporosis	0.000407	0.00152	CcSEcCtD
Iloperidone—Mental disorder—Risedronate—osteoporosis	0.000406	0.00152	CcSEcCtD
Iloperidone—Breast disorder—Estradiol—osteoporosis	0.000405	0.00151	CcSEcCtD
Iloperidone—Malnutrition—Risedronate—osteoporosis	0.000403	0.00151	CcSEcCtD
Iloperidone—Infection—Raloxifene—osteoporosis	0.000401	0.0015	CcSEcCtD
Iloperidone—Nasopharyngitis—Estradiol—osteoporosis	0.000401	0.0015	CcSEcCtD
Iloperidone—Angiopathy—Pamidronate—osteoporosis	0.0004	0.00149	CcSEcCtD
Iloperidone—Dry mouth—Calcitriol—osteoporosis	0.000399	0.00149	CcSEcCtD
Iloperidone—Muscle spasms—Ethinyl Estradiol—osteoporosis	0.000398	0.00149	CcSEcCtD
Iloperidone—Urinary tract disorder—Zoledronate—osteoporosis	0.000397	0.00148	CcSEcCtD
Iloperidone—Mediastinal disorder—Pamidronate—osteoporosis	0.000397	0.00148	CcSEcCtD
Iloperidone—Infection—Ibandronate—osteoporosis	0.000397	0.00148	CcSEcCtD
Iloperidone—Feeling abnormal—Etidronic acid—osteoporosis	0.000397	0.00148	CcSEcCtD
Iloperidone—Gastritis—Estradiol—osteoporosis	0.000397	0.00148	CcSEcCtD
Iloperidone—Nervous system disorder—Raloxifene—osteoporosis	0.000396	0.00148	CcSEcCtD
Iloperidone—Connective tissue disorder—Zoledronate—osteoporosis	0.000395	0.00148	CcSEcCtD
Iloperidone—Urethral disorder—Zoledronate—osteoporosis	0.000394	0.00147	CcSEcCtD
Iloperidone—Nervous system disorder—Ibandronate—osteoporosis	0.000392	0.00146	CcSEcCtD
Iloperidone—Muscle spasms—Risedronate—osteoporosis	0.000388	0.00145	CcSEcCtD
Iloperidone—Asthma—Estradiol—osteoporosis	0.000387	0.00145	CcSEcCtD
Iloperidone—Nausea—Ergocalciferol—osteoporosis	0.000385	0.00144	CcSEcCtD
Iloperidone—Malnutrition—Pamidronate—osteoporosis	0.000383	0.00143	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000379	0.00142	CcSEcCtD
Iloperidone—Eye disorder—Zoledronate—osteoporosis	0.000376	0.0014	CcSEcCtD
Iloperidone—Paraesthesia—Estropipate—osteoporosis	0.000374	0.0014	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000374	0.0014	CcSEcCtD
Iloperidone—Cardiac disorder—Zoledronate—osteoporosis	0.000373	0.0014	CcSEcCtD
Iloperidone—Anaemia—Risedronate—osteoporosis	0.000373	0.00139	CcSEcCtD
Iloperidone—Abdominal discomfort—Estradiol—osteoporosis	0.000371	0.00139	CcSEcCtD
Iloperidone—Somnolence—Estropipate—osteoporosis	0.00037	0.00138	CcSEcCtD
Iloperidone—Muscle spasms—Pamidronate—osteoporosis	0.000369	0.00138	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000368	0.00137	CcSEcCtD
Iloperidone—Angiopathy—Zoledronate—osteoporosis	0.000365	0.00136	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000364	0.00136	CcSEcCtD
Iloperidone—Mediastinal disorder—Zoledronate—osteoporosis	0.000363	0.00135	CcSEcCtD
Iloperidone—Vertigo—Risedronate—osteoporosis	0.000362	0.00135	CcSEcCtD
Iloperidone—Eye disorder—Conjugated Estrogens—osteoporosis	0.000362	0.00135	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Estradiol—osteoporosis	0.00036	0.00135	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Estropipate—osteoporosis	0.00036	0.00134	CcSEcCtD
Iloperidone—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.00036	0.00134	CcSEcCtD
Iloperidone—Arrhythmia—Zoledronate—osteoporosis	0.000359	0.00134	CcSEcCtD
Iloperidone—Fatigue—Estropipate—osteoporosis	0.000359	0.00134	CcSEcCtD
Iloperidone—Paraesthesia—Ibandronate—osteoporosis	0.000359	0.00134	CcSEcCtD
Iloperidone—Pollakiuria—Estradiol—osteoporosis	0.000358	0.00134	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000356	0.00133	CcSEcCtD
Iloperidone—Anaemia—Pamidronate—osteoporosis	0.000354	0.00132	CcSEcCtD
Iloperidone—Weight increased—Estradiol—osteoporosis	0.000353	0.00132	CcSEcCtD
Iloperidone—Mental disorder—Zoledronate—osteoporosis	0.000352	0.00132	CcSEcCtD
Iloperidone—Agitation—Pamidronate—osteoporosis	0.000352	0.00132	CcSEcCtD
Iloperidone—Angiopathy—Conjugated Estrogens—osteoporosis	0.000351	0.00131	CcSEcCtD
Iloperidone—Weight decreased—Estradiol—osteoporosis	0.00035	0.00131	CcSEcCtD
Iloperidone—Malnutrition—Zoledronate—osteoporosis	0.00035	0.00131	CcSEcCtD
Iloperidone—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000349	0.0013	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000348	0.0013	CcSEcCtD
Iloperidone—Somnolence—Calcitriol—osteoporosis	0.000348	0.0013	CcSEcCtD
Iloperidone—Arrhythmia—Conjugated Estrogens—osteoporosis	0.000346	0.00129	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000345	0.00129	CcSEcCtD
Iloperidone—Fatigue—Ibandronate—osteoporosis	0.000344	0.00129	CcSEcCtD
Iloperidone—Myalgia—Risedronate—osteoporosis	0.000343	0.00128	CcSEcCtD
Iloperidone—Arthralgia—Risedronate—osteoporosis	0.000343	0.00128	CcSEcCtD
Iloperidone—Leukopenia—Pamidronate—osteoporosis	0.000343	0.00128	CcSEcCtD
Iloperidone—Mental disorder—Conjugated Estrogens—osteoporosis	0.000339	0.00127	CcSEcCtD
Iloperidone—Feeling abnormal—Alendronate—osteoporosis	0.000338	0.00126	CcSEcCtD
Iloperidone—Oedema—Ethinyl Estradiol—osteoporosis	0.000338	0.00126	CcSEcCtD
Iloperidone—Malnutrition—Conjugated Estrogens—osteoporosis	0.000337	0.00126	CcSEcCtD
Iloperidone—Muscle spasms—Zoledronate—osteoporosis	0.000337	0.00126	CcSEcCtD
Iloperidone—Dry mouth—Risedronate—osteoporosis	0.000336	0.00125	CcSEcCtD
Iloperidone—Conjunctivitis—Estradiol—osteoporosis	0.000336	0.00125	CcSEcCtD
Iloperidone—Infection—Ethinyl Estradiol—osteoporosis	0.000335	0.00125	CcSEcCtD
Iloperidone—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000331	0.00124	CcSEcCtD
Iloperidone—Vision blurred—Zoledronate—osteoporosis	0.00033	0.00123	CcSEcCtD
Iloperidone—Diarrhoea—Etidronic acid—osteoporosis	0.000329	0.00123	CcSEcCtD
Iloperidone—Body temperature increased—Estropipate—osteoporosis	0.000329	0.00123	CcSEcCtD
Iloperidone—Feeling abnormal—Ibandronate—osteoporosis	0.000329	0.00123	CcSEcCtD
Iloperidone—Tremor—Zoledronate—osteoporosis	0.000328	0.00123	CcSEcCtD
Iloperidone—Infection—Risedronate—osteoporosis	0.000327	0.00122	CcSEcCtD
Iloperidone—Hepatobiliary disease—Estradiol—osteoporosis	0.000327	0.00122	CcSEcCtD
Iloperidone—Arthralgia—Pamidronate—osteoporosis	0.000326	0.00122	CcSEcCtD
Iloperidone—Myalgia—Pamidronate—osteoporosis	0.000326	0.00122	CcSEcCtD
Iloperidone—Epistaxis—Estradiol—osteoporosis	0.000326	0.00122	CcSEcCtD
Iloperidone—Body temperature increased—Alendronate—osteoporosis	0.000324	0.00121	CcSEcCtD
Iloperidone—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000324	0.00121	CcSEcCtD
Iloperidone—Anaemia—Zoledronate—osteoporosis	0.000324	0.00121	CcSEcCtD
Iloperidone—Nervous system disorder—Risedronate—osteoporosis	0.000323	0.00121	CcSEcCtD
Iloperidone—Agitation—Zoledronate—osteoporosis	0.000322	0.0012	CcSEcCtD
Iloperidone—Body temperature increased—Raloxifene—osteoporosis	0.000319	0.00119	CcSEcCtD
Iloperidone—Vision blurred—Conjugated Estrogens—osteoporosis	0.000318	0.00119	CcSEcCtD
Iloperidone—Body temperature increased—Ibandronate—osteoporosis	0.000316	0.00118	CcSEcCtD
Iloperidone—Confusional state—Pamidronate—osteoporosis	0.000316	0.00118	CcSEcCtD
Iloperidone—Vertigo—Zoledronate—osteoporosis	0.000315	0.00118	CcSEcCtD
Iloperidone—Leukopenia—Zoledronate—osteoporosis	0.000313	0.00117	CcSEcCtD
Iloperidone—Oedema—Pamidronate—osteoporosis	0.000313	0.00117	CcSEcCtD
Iloperidone—Infection—Pamidronate—osteoporosis	0.000311	0.00116	CcSEcCtD
Iloperidone—Palpitations—Zoledronate—osteoporosis	0.000309	0.00116	CcSEcCtD
Iloperidone—Body temperature increased—Calcitriol—osteoporosis	0.000309	0.00115	CcSEcCtD
Iloperidone—Nervous system disorder—Pamidronate—osteoporosis	0.000307	0.00115	CcSEcCtD
Iloperidone—Urinary tract disorder—Estradiol—osteoporosis	0.000306	0.00114	CcSEcCtD
Iloperidone—Tachycardia—Pamidronate—osteoporosis	0.000305	0.00114	CcSEcCtD
Iloperidone—Connective tissue disorder—Estradiol—osteoporosis	0.000305	0.00114	CcSEcCtD
Iloperidone—Urethral disorder—Estradiol—osteoporosis	0.000304	0.00114	CcSEcCtD
Iloperidone—Rash—Etidronic acid—osteoporosis	0.000304	0.00113	CcSEcCtD
Iloperidone—Dermatitis—Etidronic acid—osteoporosis	0.000303	0.00113	CcSEcCtD
Iloperidone—Vertigo—Conjugated Estrogens—osteoporosis	0.000303	0.00113	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Risedronate—osteoporosis	0.0003	0.00112	CcSEcCtD
Iloperidone—Asthenia—Estropipate—osteoporosis	0.000299	0.00112	CcSEcCtD
Iloperidone—Myalgia—Zoledronate—osteoporosis	0.000298	0.00111	CcSEcCtD
Iloperidone—Arthralgia—Zoledronate—osteoporosis	0.000298	0.00111	CcSEcCtD
Iloperidone—Palpitations—Conjugated Estrogens—osteoporosis	0.000298	0.00111	CcSEcCtD
Iloperidone—Paraesthesia—Risedronate—osteoporosis	0.000296	0.0011	CcSEcCtD
Iloperidone—Asthenia—Alendronate—osteoporosis	0.000294	0.0011	CcSEcCtD
Iloperidone—Dyspnoea—Risedronate—osteoporosis	0.000293	0.0011	CcSEcCtD
Iloperidone—Hypotension—Pamidronate—osteoporosis	0.000292	0.00109	CcSEcCtD
Iloperidone—Dry mouth—Zoledronate—osteoporosis	0.000292	0.00109	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000291	0.00109	CcSEcCtD
Iloperidone—Fatigue—Ethinyl Estradiol—osteoporosis	0.000291	0.00109	CcSEcCtD
Iloperidone—Eye disorder—Estradiol—osteoporosis	0.00029	0.00108	CcSEcCtD
Iloperidone—Tinnitus—Estradiol—osteoporosis	0.000289	0.00108	CcSEcCtD
Iloperidone—Confusional state—Zoledronate—osteoporosis	0.000288	0.00108	CcSEcCtD
Iloperidone—Cardiac disorder—Estradiol—osteoporosis	0.000288	0.00108	CcSEcCtD
Iloperidone—Arthralgia—Conjugated Estrogens—osteoporosis	0.000287	0.00107	CcSEcCtD
Iloperidone—Myalgia—Conjugated Estrogens—osteoporosis	0.000287	0.00107	CcSEcCtD
Iloperidone—Asthenia—Ibandronate—osteoporosis	0.000287	0.00107	CcSEcCtD
Iloperidone—Nausea—Etidronic acid—osteoporosis	0.000286	0.00107	CcSEcCtD
Iloperidone—Oedema—Zoledronate—osteoporosis	0.000286	0.00107	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000285	0.00107	CcSEcCtD
Iloperidone—Diarrhoea—Estropipate—osteoporosis	0.000285	0.00106	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Risedronate—osteoporosis	0.000284	0.00106	CcSEcCtD
Iloperidone—Infection—Zoledronate—osteoporosis	0.000284	0.00106	CcSEcCtD
Iloperidone—Fatigue—Risedronate—osteoporosis	0.000284	0.00106	CcSEcCtD
Iloperidone—Angiopathy—Estradiol—osteoporosis	0.000281	0.00105	CcSEcCtD
Iloperidone—Paraesthesia—Pamidronate—osteoporosis	0.000281	0.00105	CcSEcCtD
Iloperidone—Diarrhoea—Alendronate—osteoporosis	0.000281	0.00105	CcSEcCtD
Iloperidone—Asthenia—Calcitriol—osteoporosis	0.000281	0.00105	CcSEcCtD
Iloperidone—Nervous system disorder—Zoledronate—osteoporosis	0.00028	0.00105	CcSEcCtD
Iloperidone—Mediastinal disorder—Estradiol—osteoporosis	0.000279	0.00104	CcSEcCtD
Iloperidone—Dyspnoea—Pamidronate—osteoporosis	0.000279	0.00104	CcSEcCtD
Iloperidone—Tachycardia—Zoledronate—osteoporosis	0.000279	0.00104	CcSEcCtD
Iloperidone—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000278	0.00104	CcSEcCtD
Iloperidone—Somnolence—Pamidronate—osteoporosis	0.000278	0.00104	CcSEcCtD
Iloperidone—Diarrhoea—Raloxifene—osteoporosis	0.000276	0.00103	CcSEcCtD
Iloperidone—Dizziness—Estropipate—osteoporosis	0.000275	0.00103	CcSEcCtD
Iloperidone—Oedema—Conjugated Estrogens—osteoporosis	0.000275	0.00103	CcSEcCtD
Iloperidone—Infection—Conjugated Estrogens—osteoporosis	0.000273	0.00102	CcSEcCtD
Iloperidone—Diarrhoea—Ibandronate—osteoporosis	0.000273	0.00102	CcSEcCtD
Iloperidone—Mental disorder—Estradiol—osteoporosis	0.000272	0.00101	CcSEcCtD
Iloperidone—Dizziness—Alendronate—osteoporosis	0.000271	0.00101	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00027	0.00101	CcSEcCtD
Iloperidone—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00027	0.00101	CcSEcCtD
Iloperidone—Malnutrition—Estradiol—osteoporosis	0.00027	0.00101	CcSEcCtD
Iloperidone—Fatigue—Pamidronate—osteoporosis	0.00027	0.00101	CcSEcCtD
Iloperidone—Tachycardia—Conjugated Estrogens—osteoporosis	0.000269	0.001	CcSEcCtD
Iloperidone—Diarrhoea—Calcitriol—osteoporosis	0.000268	0.001	CcSEcCtD
Iloperidone—Hypotension—Zoledronate—osteoporosis	0.000267	0.000998	CcSEcCtD
Iloperidone—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000267	0.000997	CcSEcCtD
Iloperidone—Dizziness—Raloxifene—osteoporosis	0.000267	0.000997	CcSEcCtD
Iloperidone—Dizziness—Ibandronate—osteoporosis	0.000264	0.000987	CcSEcCtD
Iloperidone—Rash—Estropipate—osteoporosis	0.000263	0.000981	CcSEcCtD
Iloperidone—Dermatitis—Estropipate—osteoporosis	0.000262	0.00098	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00026	0.000973	CcSEcCtD
Iloperidone—Body temperature increased—Risedronate—osteoporosis	0.00026	0.000972	CcSEcCtD
Iloperidone—Muscle spasms—Estradiol—osteoporosis	0.000259	0.00097	CcSEcCtD
Iloperidone—Rash—Alendronate—osteoporosis	0.000259	0.000967	CcSEcCtD
Iloperidone—Dermatitis—Alendronate—osteoporosis	0.000258	0.000966	CcSEcCtD
Iloperidone—Feeling abnormal—Pamidronate—osteoporosis	0.000258	0.000964	CcSEcCtD
Iloperidone—Hypotension—Conjugated Estrogens—osteoporosis	0.000257	0.000961	CcSEcCtD
Iloperidone—Paraesthesia—Zoledronate—osteoporosis	0.000257	0.000959	CcSEcCtD
Iloperidone—Dyspnoea—Zoledronate—osteoporosis	0.000255	0.000952	CcSEcCtD
Iloperidone—Rash—Raloxifene—osteoporosis	0.000254	0.000951	CcSEcCtD
Iloperidone—Dermatitis—Raloxifene—osteoporosis	0.000254	0.00095	CcSEcCtD
Iloperidone—Somnolence—Zoledronate—osteoporosis	0.000254	0.000949	CcSEcCtD
Iloperidone—Tremor—Estradiol—osteoporosis	0.000253	0.000945	CcSEcCtD
Iloperidone—Rash—Ibandronate—osteoporosis	0.000252	0.000941	CcSEcCtD
Iloperidone—Dermatitis—Ibandronate—osteoporosis	0.000252	0.00094	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000251	0.000937	CcSEcCtD
Iloperidone—Agitation—Estradiol—osteoporosis	0.000248	0.000927	CcSEcCtD
Iloperidone—Nausea—Estropipate—osteoporosis	0.000247	0.000924	CcSEcCtD
Iloperidone—Body temperature increased—Pamidronate—osteoporosis	0.000247	0.000924	CcSEcCtD
Iloperidone—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000247	0.000923	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000247	0.000922	CcSEcCtD
Iloperidone—Rash—Calcitriol—osteoporosis	0.000247	0.000921	CcSEcCtD
Iloperidone—Fatigue—Zoledronate—osteoporosis	0.000246	0.000921	CcSEcCtD
Iloperidone—Dermatitis—Calcitriol—osteoporosis	0.000246	0.00092	CcSEcCtD
Iloperidone—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000245	0.000917	CcSEcCtD
Iloperidone—Somnolence—Conjugated Estrogens—osteoporosis	0.000245	0.000914	CcSEcCtD
Iloperidone—Nausea—Alendronate—osteoporosis	0.000244	0.000911	CcSEcCtD
Iloperidone—Vertigo—Estradiol—osteoporosis	0.000242	0.000906	CcSEcCtD
Iloperidone—Asthenia—Ethinyl Estradiol—osteoporosis	0.000242	0.000905	CcSEcCtD
Iloperidone—Nausea—Raloxifene—osteoporosis	0.00024	0.000895	CcSEcCtD
Iloperidone—Palpitations—Estradiol—osteoporosis	0.000239	0.000891	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000238	0.000888	CcSEcCtD
Iloperidone—Fatigue—Conjugated Estrogens—osteoporosis	0.000237	0.000887	CcSEcCtD
Iloperidone—Nausea—Ibandronate—osteoporosis	0.000237	0.000886	CcSEcCtD
Iloperidone—Asthenia—Risedronate—osteoporosis	0.000236	0.000882	CcSEcCtD
Iloperidone—Feeling abnormal—Zoledronate—osteoporosis	0.000236	0.00088	CcSEcCtD
Iloperidone—Nausea—Calcitriol—osteoporosis	0.000232	0.000868	CcSEcCtD
Iloperidone—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000231	0.000863	CcSEcCtD
Iloperidone—Myalgia—Estradiol—osteoporosis	0.00023	0.000859	CcSEcCtD
Iloperidone—Arthralgia—Estradiol—osteoporosis	0.00023	0.000859	CcSEcCtD
Iloperidone—Body temperature increased—Zoledronate—osteoporosis	0.000226	0.000844	CcSEcCtD
Iloperidone—Diarrhoea—Risedronate—osteoporosis	0.000225	0.000842	CcSEcCtD
Iloperidone—Dry mouth—Estradiol—osteoporosis	0.000225	0.00084	CcSEcCtD
Iloperidone—Asthenia—Pamidronate—osteoporosis	0.000225	0.000839	CcSEcCtD
Iloperidone—Dizziness—Ethinyl Estradiol—osteoporosis	0.000223	0.000834	CcSEcCtD
Iloperidone—Confusional state—Estradiol—osteoporosis	0.000222	0.00083	CcSEcCtD
Iloperidone—Oedema—Estradiol—osteoporosis	0.00022	0.000823	CcSEcCtD
Iloperidone—Infection—Estradiol—osteoporosis	0.000219	0.000818	CcSEcCtD
Iloperidone—Dizziness—Risedronate—osteoporosis	0.000218	0.000813	CcSEcCtD
Iloperidone—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000218	0.000813	CcSEcCtD
Iloperidone—Nervous system disorder—Estradiol—osteoporosis	0.000216	0.000807	CcSEcCtD
Iloperidone—Tachycardia—Estradiol—osteoporosis	0.000215	0.000803	CcSEcCtD
Iloperidone—Diarrhoea—Pamidronate—osteoporosis	0.000214	0.0008	CcSEcCtD
Iloperidone—Rash—Ethinyl Estradiol—osteoporosis	0.000213	0.000795	CcSEcCtD
Iloperidone—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000213	0.000795	CcSEcCtD
Iloperidone—Rash—Risedronate—osteoporosis	0.000208	0.000776	CcSEcCtD
Iloperidone—Dermatitis—Risedronate—osteoporosis	0.000207	0.000775	CcSEcCtD
Iloperidone—Dizziness—Pamidronate—osteoporosis	0.000207	0.000773	CcSEcCtD
Iloperidone—Asthenia—Zoledronate—osteoporosis	0.000205	0.000766	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000201	0.00075	CcSEcCtD
Iloperidone—Nausea—Ethinyl Estradiol—osteoporosis	0.000201	0.000749	CcSEcCtD
Iloperidone—Paraesthesia—Estradiol—osteoporosis	0.000198	0.000739	CcSEcCtD
Iloperidone—Asthenia—Conjugated Estrogens—osteoporosis	0.000197	0.000738	CcSEcCtD
Iloperidone—Rash—Pamidronate—osteoporosis	0.000197	0.000737	CcSEcCtD
Iloperidone—Dermatitis—Pamidronate—osteoporosis	0.000197	0.000737	CcSEcCtD
Iloperidone—Dyspnoea—Estradiol—osteoporosis	0.000196	0.000734	CcSEcCtD
Iloperidone—Somnolence—Estradiol—osteoporosis	0.000196	0.000732	CcSEcCtD
Iloperidone—Diarrhoea—Zoledronate—osteoporosis	0.000196	0.000731	CcSEcCtD
Iloperidone—Nausea—Risedronate—osteoporosis	0.000196	0.000731	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Estradiol—osteoporosis	0.00019	0.000711	CcSEcCtD
Iloperidone—Fatigue—Estradiol—osteoporosis	0.00019	0.00071	CcSEcCtD
Iloperidone—Dizziness—Zoledronate—osteoporosis	0.000189	0.000706	CcSEcCtD
Iloperidone—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000188	0.000704	CcSEcCtD
Iloperidone—Nausea—Pamidronate—osteoporosis	0.000186	0.000694	CcSEcCtD
Iloperidone—Dizziness—Conjugated Estrogens—osteoporosis	0.000182	0.00068	CcSEcCtD
Iloperidone—Feeling abnormal—Estradiol—osteoporosis	0.000182	0.000678	CcSEcCtD
Iloperidone—Rash—Zoledronate—osteoporosis	0.00018	0.000673	CcSEcCtD
Iloperidone—Dermatitis—Zoledronate—osteoporosis	0.00018	0.000673	CcSEcCtD
Iloperidone—Body temperature increased—Estradiol—osteoporosis	0.000174	0.000651	CcSEcCtD
Iloperidone—Rash—Conjugated Estrogens—osteoporosis	0.000174	0.000648	CcSEcCtD
Iloperidone—Dermatitis—Conjugated Estrogens—osteoporosis	0.000173	0.000648	CcSEcCtD
Iloperidone—Nausea—Zoledronate—osteoporosis	0.00017	0.000634	CcSEcCtD
Iloperidone—Nausea—Conjugated Estrogens—osteoporosis	0.000163	0.000611	CcSEcCtD
Iloperidone—Asthenia—Estradiol—osteoporosis	0.000158	0.000591	CcSEcCtD
Iloperidone—Diarrhoea—Estradiol—osteoporosis	0.000151	0.000563	CcSEcCtD
Iloperidone—Dizziness—Estradiol—osteoporosis	0.000146	0.000544	CcSEcCtD
Iloperidone—Rash—Estradiol—osteoporosis	0.000139	0.000519	CcSEcCtD
Iloperidone—Dermatitis—Estradiol—osteoporosis	0.000139	0.000518	CcSEcCtD
Iloperidone—Nausea—Estradiol—osteoporosis	0.000131	0.000489	CcSEcCtD
Iloperidone—CYP3A4—Metabolism—MGLL—osteoporosis	1.47e-05	0.000168	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—ADCY5—osteoporosis	1.46e-05	0.000168	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.46e-05	0.000167	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—RAP1A—osteoporosis	1.46e-05	0.000167	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—POMC—osteoporosis	1.46e-05	0.000167	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—ADCY5—osteoporosis	1.45e-05	0.000167	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—LEP—osteoporosis	1.45e-05	0.000167	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—LEP—osteoporosis	1.45e-05	0.000166	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—GPX1—osteoporosis	1.45e-05	0.000166	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—CYP19A1—osteoporosis	1.45e-05	0.000166	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—LEP—osteoporosis	1.44e-05	0.000165	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—ADCY5—osteoporosis	1.44e-05	0.000165	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—IRS2—osteoporosis	1.42e-05	0.000163	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—SPP1—osteoporosis	1.41e-05	0.000162	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—KL—osteoporosis	1.41e-05	0.000161	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—SPP1—osteoporosis	1.39e-05	0.00016	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—LEP—osteoporosis	1.39e-05	0.000159	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CALCA—osteoporosis	1.39e-05	0.000159	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—ESR1—osteoporosis	1.39e-05	0.000159	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—ESR1—osteoporosis	1.39e-05	0.000159	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—KL—osteoporosis	1.39e-05	0.000159	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—KL—osteoporosis	1.38e-05	0.000159	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—MTHFR—osteoporosis	1.38e-05	0.000158	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—ESR1—osteoporosis	1.38e-05	0.000158	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—TPI1—osteoporosis	1.37e-05	0.000157	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—POMC—osteoporosis	1.37e-05	0.000157	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—KL—osteoporosis	1.36e-05	0.000156	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	1.35e-05	0.000155	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—POMC—osteoporosis	1.35e-05	0.000155	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—POMC—osteoporosis	1.35e-05	0.000155	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—IL6R—osteoporosis	1.34e-05	0.000154	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—MTHFR—osteoporosis	1.34e-05	0.000153	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—CYP19A1—osteoporosis	1.33e-05	0.000152	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—ESR1—osteoporosis	1.33e-05	0.000152	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—CYP19A1—osteoporosis	1.32e-05	0.000152	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—POMC—osteoporosis	1.32e-05	0.000152	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—IL6R—osteoporosis	1.32e-05	0.000151	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—IL6R—osteoporosis	1.32e-05	0.000151	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—IRS1—osteoporosis	1.3e-05	0.000149	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—IRS1—osteoporosis	1.3e-05	0.000148	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—P4HB—osteoporosis	1.29e-05	0.000148	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	1.29e-05	0.000148	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—IRS1—osteoporosis	1.29e-05	0.000148	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—IRS2—osteoporosis	1.28e-05	0.000147	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—GAPDH—osteoporosis	1.27e-05	0.000145	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—IRS2—osteoporosis	1.26e-05	0.000145	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—KL—osteoporosis	1.26e-05	0.000145	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—ADCY5—osteoporosis	1.26e-05	0.000144	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—LEP—osteoporosis	1.25e-05	0.000143	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—ADCY5—osteoporosis	1.25e-05	0.000143	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—POMC—osteoporosis	1.25e-05	0.000143	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—POMC—osteoporosis	1.25e-05	0.000143	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—IDH2—osteoporosis	1.25e-05	0.000143	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—IRS1—osteoporosis	1.24e-05	0.000142	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—POMC—osteoporosis	1.24e-05	0.000142	CbGpPWpGaD
Iloperidone—ADRA2A—Hemostasis—TGFB1—osteoporosis	1.24e-05	0.000142	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—RAP1A—osteoporosis	1.23e-05	0.000142	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—LEP—osteoporosis	1.23e-05	0.000142	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—POMC—osteoporosis	1.23e-05	0.000141	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—IL6R—osteoporosis	1.22e-05	0.00014	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—IL6R—osteoporosis	1.22e-05	0.000139	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—ADCY5—osteoporosis	1.22e-05	0.000139	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—SPP1—osteoporosis	1.22e-05	0.000139	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—SPP1—osteoporosis	1.21e-05	0.000139	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—IL6R—osteoporosis	1.21e-05	0.000139	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—IGF1—osteoporosis	1.2e-05	0.000138	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—IGF1—osteoporosis	1.2e-05	0.000138	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	1.2e-05	0.000138	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—ESR1—osteoporosis	1.19e-05	0.000137	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—POMC—osteoporosis	1.19e-05	0.000137	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—IGF1—osteoporosis	1.19e-05	0.000137	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—ADCY5—osteoporosis	1.18e-05	0.000135	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—ESR1—osteoporosis	1.18e-05	0.000135	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—ENO1—osteoporosis	1.18e-05	0.000135	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—GPX1—osteoporosis	1.18e-05	0.000135	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—SPP1—osteoporosis	1.18e-05	0.000135	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.17e-05	0.000134	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—IL6R—osteoporosis	1.16e-05	0.000134	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PSMA5—osteoporosis	1.16e-05	0.000133	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PSMA2—osteoporosis	1.16e-05	0.000133	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—IGF1—osteoporosis	1.15e-05	0.000132	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ACP5—osteoporosis	1.14e-05	0.000131	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—IRS1—osteoporosis	1.12e-05	0.000128	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—ADCY5—osteoporosis	1.1e-05	0.000126	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—POMC—osteoporosis	1.1e-05	0.000126	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—IRS1—osteoporosis	1.1e-05	0.000126	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.1e-05	0.000126	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—IRS2—osteoporosis	1.09e-05	0.000125	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—MTHFR—osteoporosis	1.09e-05	0.000125	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—ADCY5—osteoporosis	1.09e-05	0.000124	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—ADCY5—osteoporosis	1.08e-05	0.000124	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—ADCY5—osteoporosis	1.08e-05	0.000124	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—ADCY5—osteoporosis	1.08e-05	0.000124	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—GPX1—osteoporosis	1.08e-05	0.000124	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—GPX1—osteoporosis	1.08e-05	0.000124	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.08e-05	0.000123	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—LEP—osteoporosis	1.08e-05	0.000123	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—POMC—osteoporosis	1.07e-05	0.000123	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—LEP—osteoporosis	1.07e-05	0.000123	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—POMC—osteoporosis	1.07e-05	0.000123	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—SPP1—osteoporosis	1.07e-05	0.000122	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—IRS2—osteoporosis	1.06e-05	0.000122	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	1.06e-05	0.000122	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—POMC—osteoporosis	1.06e-05	0.000122	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—TPI1—osteoporosis	1.06e-05	0.000122	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—SPP1—osteoporosis	1.05e-05	0.00012	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—IL6R—osteoporosis	1.05e-05	0.00012	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—SPP1—osteoporosis	1.05e-05	0.00012	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—LEP—osteoporosis	1.04e-05	0.000119	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—IL6R—osteoporosis	1.03e-05	0.000119	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—IGF1—osteoporosis	1.03e-05	0.000119	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—SPP1—osteoporosis	1.03e-05	0.000118	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—ESR1—osteoporosis	1.03e-05	0.000118	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—ESR1—osteoporosis	1.02e-05	0.000117	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—IGF1—osteoporosis	1.02e-05	0.000117	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—ENO1—osteoporosis	9.98e-06	0.000114	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—MTHFR—osteoporosis	9.98e-06	0.000114	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—P4HB—osteoporosis	9.97e-06	0.000114	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—MTHFR—osteoporosis	9.95e-06	0.000114	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—ESR1—osteoporosis	9.94e-06	0.000114	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	9.88e-06	0.000113	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PSMA2—osteoporosis	9.84e-06	0.000113	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PSMA5—osteoporosis	9.84e-06	0.000113	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GAPDH—osteoporosis	9.78e-06	0.000112	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—IRS2—osteoporosis	9.65e-06	0.000111	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—IRS1—osteoporosis	9.6e-06	0.00011	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—SPP1—osteoporosis	9.56e-06	0.00011	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—IRS1—osteoporosis	9.55e-06	0.000109	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—RAP1A—osteoporosis	9.53e-06	0.000109	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—IRS2—osteoporosis	9.5e-06	0.000109	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—IRS2—osteoporosis	9.48e-06	0.000109	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—LEP—osteoporosis	9.45e-06	0.000108	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—CYP19A1—osteoporosis	9.42e-06	0.000108	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IRS2—osteoporosis	9.3e-06	0.000107	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—LEP—osteoporosis	9.29e-06	0.000107	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—IRS1—osteoporosis	9.29e-06	0.000106	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—LEP—osteoporosis	9.27e-06	0.000106	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—POMC—osteoporosis	9.24e-06	0.000106	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—POMC—osteoporosis	9.2e-06	0.000105	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—IL6—osteoporosis	9.18e-06	0.000105	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—IL6—osteoporosis	9.17e-06	0.000105	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—IL6—osteoporosis	9.11e-06	0.000104	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—LEP—osteoporosis	9.1e-06	0.000104	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—ESR1—osteoporosis	9.02e-06	0.000103	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—IL6R—osteoporosis	9.02e-06	0.000103	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—IL6R—osteoporosis	8.97e-06	0.000103	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—POMC—osteoporosis	8.94e-06	0.000103	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—IGF1—osteoporosis	8.89e-06	0.000102	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—ESR1—osteoporosis	8.87e-06	0.000102	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—ESR1—osteoporosis	8.86e-06	0.000102	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—IGF1—osteoporosis	8.84e-06	0.000101	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—IL6—osteoporosis	8.78e-06	0.000101	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—IL6R—osteoporosis	8.72e-06	0.0001	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—ESR1—osteoporosis	8.69e-06	9.96e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—POMC—osteoporosis	8.69e-06	9.96e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IRS2—osteoporosis	8.64e-06	9.91e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—IGF1—osteoporosis	8.6e-06	9.86e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—LEP—osteoporosis	8.46e-06	9.69e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—IRS1—osteoporosis	8.43e-06	9.66e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—IRS1—osteoporosis	8.29e-06	9.51e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—IRS1—osteoporosis	8.27e-06	9.48e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IRS1—osteoporosis	8.12e-06	9.31e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—POMC—osteoporosis	8.12e-06	9.3e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—ESR1—osteoporosis	8.07e-06	9.25e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—POMC—osteoporosis	7.98e-06	9.15e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—CYP19A1—osteoporosis	7.98e-06	9.15e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—POMC—osteoporosis	7.98e-06	9.15e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—POMC—osteoporosis	7.97e-06	9.13e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—POMC—osteoporosis	7.96e-06	9.13e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—IL6R—osteoporosis	7.92e-06	9.07e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—IL6—osteoporosis	7.91e-06	9.06e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—POMC—osteoporosis	7.82e-06	8.96e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—IGF1—osteoporosis	7.81e-06	8.95e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—IL6—osteoporosis	7.8e-06	8.94e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—IL6R—osteoporosis	7.79e-06	8.93e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—IL6R—osteoporosis	7.77e-06	8.91e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ENO1—osteoporosis	7.7e-06	8.83e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—ADCY5—osteoporosis	7.7e-06	8.82e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—IGF1—osteoporosis	7.68e-06	8.8e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—GPX1—osteoporosis	7.67e-06	8.79e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—IGF1—osteoporosis	7.66e-06	8.79e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IL6R—osteoporosis	7.63e-06	8.74e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PSMA5—osteoporosis	7.59e-06	8.7e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PSMA2—osteoporosis	7.59e-06	8.7e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IRS1—osteoporosis	7.54e-06	8.65e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IGF1—osteoporosis	7.52e-06	8.62e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—POMC—osteoporosis	7.26e-06	8.33e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—MYC—osteoporosis	7.22e-06	8.27e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—MYC—osteoporosis	7.21e-06	8.27e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—TGFB1—osteoporosis	7.2e-06	8.25e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—TGFB1—osteoporosis	7.19e-06	8.24e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—MYC—osteoporosis	7.16e-06	8.21e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—TGFB1—osteoporosis	7.15e-06	8.19e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IL6R—osteoporosis	7.09e-06	8.12e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—MTHFR—osteoporosis	7.08e-06	8.11e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IGF1—osteoporosis	6.99e-06	8.01e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—MYC—osteoporosis	6.9e-06	7.91e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—TGFB1—osteoporosis	6.89e-06	7.89e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—IL6—osteoporosis	6.8e-06	7.79e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—IL6—osteoporosis	6.76e-06	7.75e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—IL6—osteoporosis	6.58e-06	7.54e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—ADCY5—osteoporosis	6.52e-06	7.47e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—GPX1—osteoporosis	6.5e-06	7.45e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—MYC—osteoporosis	6.21e-06	7.12e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—TGFB1—osteoporosis	6.2e-06	7.11e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CYP19A1—osteoporosis	6.16e-06	7.06e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—MYC—osteoporosis	6.13e-06	7.03e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—TGFB1—osteoporosis	6.12e-06	7.01e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—MTHFR—osteoporosis	6e-06	6.87e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—IL6—osteoporosis	5.97e-06	6.84e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—IL6—osteoporosis	5.87e-06	6.73e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—IL6—osteoporosis	5.86e-06	6.72e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—IL6—osteoporosis	5.75e-06	6.59e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—POMC—osteoporosis	5.66e-06	6.49e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—IL6—osteoporosis	5.43e-06	6.22e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—IL6—osteoporosis	5.42e-06	6.21e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—IL6—osteoporosis	5.38e-06	6.17e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—IL6—osteoporosis	5.34e-06	6.13e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—MYC—osteoporosis	5.34e-06	6.12e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—TGFB1—osteoporosis	5.33e-06	6.11e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—MYC—osteoporosis	5.32e-06	6.09e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—TGFB1—osteoporosis	5.3e-06	6.08e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—IL6—osteoporosis	5.19e-06	5.95e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—MYC—osteoporosis	5.17e-06	5.93e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—TGFB1—osteoporosis	5.16e-06	5.91e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ADCY5—osteoporosis	5.03e-06	5.77e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GPX1—osteoporosis	5.01e-06	5.75e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—POMC—osteoporosis	4.8e-06	5.5e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—MYC—osteoporosis	4.69e-06	5.38e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—TGFB1—osteoporosis	4.68e-06	5.36e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—IL6—osteoporosis	4.67e-06	5.35e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—MTHFR—osteoporosis	4.63e-06	5.31e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—MYC—osteoporosis	4.62e-06	5.29e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—IL6—osteoporosis	4.61e-06	5.28e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—MYC—osteoporosis	4.61e-06	5.28e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—TGFB1—osteoporosis	4.6e-06	5.28e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—TGFB1—osteoporosis	4.59e-06	5.27e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—MYC—osteoporosis	4.52e-06	5.18e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	4.51e-06	5.17e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—MYC—osteoporosis	4.2e-06	4.81e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	4.19e-06	4.8e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—IL6—osteoporosis	4.02e-06	4.6e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—IL6—osteoporosis	4e-06	4.58e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—IL6—osteoporosis	3.89e-06	4.46e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—POMC—osteoporosis	3.7e-06	4.24e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—IL6—osteoporosis	3.53e-06	4.04e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—IL6—osteoporosis	3.47e-06	3.98e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—IL6—osteoporosis	3.46e-06	3.97e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IL6—osteoporosis	3.4e-06	3.89e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IL6—osteoporosis	3.16e-06	3.62e-05	CbGpPWpGaD
